Cigarette smoking and mortality risk in people with schizophrenia.
about
Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.Smoking cessation and reduction in people with chronic mental illnessPerception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophreniaInflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders.Mortality in schizophrenia: clinical and serological predictorsClinical characteristics of heavy and non-heavy smokers with schizophrenia.Prevalence of cardiovascular risk factors among racial and ethnic minorities with schizophrenia spectrum and bipolar disorders: a critical literature review.Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?Association between schizophrenia symptoms and neurocognition on mobility in older adults with schizophreniaMortality in schizophrenia and other psychoses: a 10-year follow-up of the ӔSOP first-episode cohort.Tobacco craving in smokers with and without schizophrenia.Prevalence and correlates of cigarette smoking among Chinese schizophrenia inpatients receiving antipsychotic mono-therapyGAD2 Alternative Transcripts in the Human Prefrontal Cortex, and in Schizophrenia and Affective Disorders.Smoking and environmental characteristics of smokers with a mental illness, and associations with quitting behaviour and motivation; a cross sectional study.Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders.Illicit drug use in heavy smokers with and without schizophrenia.Peer Supports for Tobacco Cessation for Adults with Serious Mental Illness: A Review of the Literature.Rapid smoking may not be aversive in schizophrenia.Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study.Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trialSmoking among individuals with schizophrenia in Korea: gender differencesDetection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia.Smoking behaviour and mental health disorders--mutual influences and implications for therapySmoking cessation and reduction in schizophrenia (SCARIS) with e-cigarette: study protocol for a randomized control trial.A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications.How can we promote smoking cessation in people with schizophrenia in practice? A clinical overview.Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness.Potential uses of Bayesian networks as tools for synthesis of systematic reviews of complex interventions.Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.Association between antipsychotics and cardiovascular adverse events: A systematic review.Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis.Predictors of the Perception of Smoking Health Risks in Smokers With or Without Schizophrenia.The effect of nicotine dependence on psychopathology in patients with schizophrenia.Impaired Coupling between the Dorsomedial Prefrontal Cortex and the Amygdala in Schizophrenia Smokers Viewing Anti-smoking Images.Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.Cigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control study.Diabetes Screening among Antipsychotic-Treated Adults with Severe Mental Illness in an Integrated Delivery System: A Retrospective Cohort Study.Utilization of the Behavior Change Wheel framework to develop a model to improve cardiometabolic screening for people with severe mental illness.Psychoactive substance use in specialized psychiatric care patients.Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia.
P2860
Q21129280-69634CA7-8D89-45A2-9699-3BB6C48644BBQ26782639-FDC106D9-93AB-4002-8B13-0D310C49C699Q30455113-A1379749-1C2F-4B32-B8AC-E6E6D86C22F0Q33721019-18391325-610C-4C3F-AA81-068C2326453BQ33762540-6A13AD99-B7AB-4EBD-953A-10819FF1610FQ33775576-8FE86EE2-A7A7-4723-A1C7-D0DEA3354480Q34181934-EFE37D96-7148-4519-A6AA-5B31C4CBCEB3Q34183495-135BBCDF-EA81-483E-A81C-48452C2B4BD7Q34254308-D3DEACF9-68BF-4D4C-A22C-789870B60D2CQ34440708-5F8DB6AB-2EBD-4B02-A6EA-2EB44AAE39F2Q34634287-CAAE8031-372A-40FD-B41B-5D232A8FF9A1Q35092839-4D9F32E1-A17C-405A-8CDA-984E15152A74Q35915500-66E4F78A-4D22-43EE-9B65-6F63F9A10DE5Q35990347-2D8A2DBB-6BEA-4A2C-8092-D9B5093083FFQ36083997-8DBF873C-38FB-4CEC-A8D5-214C809B2CB5Q36087073-0F298523-82A2-4355-BF9B-F656A2FA6596Q36165689-1A2BD2B2-C74D-4980-BA9A-F3D376076216Q36471911-EA3E175F-A1E9-4E85-B03B-9C4EA9CDEE56Q36953614-1AFE803F-D2A8-4B2D-BFC0-95A0BAE6FE27Q37184340-7CD2D38D-8D33-4E51-A6BD-A6D2A0B64C94Q37203710-62221BAD-B539-44F5-9C1C-096572E28938Q37231225-950A79B8-49E4-4A4F-8791-AED1D32B7259Q37295878-D23EE000-5BCF-4105-B8C2-E2D1BA078BCFQ37714728-8AF9DC62-9F81-44C8-8B04-59F7F8B935BEQ37998841-8ECA1790-DECE-43DC-B8E3-7E82B077B26CQ38371207-5FC604B4-0642-440B-9421-EE607785D81EQ38395288-BE7D22EA-A1D5-467A-89E6-B855736E0CD1Q38520542-B04D4052-39FA-4DC7-97F3-70D8C815A50AQ38544976-6F83CD76-AE56-4406-9518-56D8EDA3C388Q38794493-1B39F793-6178-49A3-B59A-C9EF900ADA60Q38797685-57CDE1F0-1C8E-4120-AAAC-3C429794CD71Q39163931-55D8FA61-6CD3-4F0A-BAAC-BE5279A22521Q40548353-C8A46450-B80F-41C0-B8BE-382647DEFAC9Q42176379-C428C984-DC7A-423B-B44D-D3FC4EADD423Q42251217-10B9EF6D-9CC7-4C47-B11B-F1C49635E5F7Q44966103-0B9AC55C-B78D-4057-B06F-DEEB10976419Q46642105-4460D356-715F-4145-A02D-096BA4A8034AQ47141502-A28D1EFD-10A1-4E28-8701-42F8754666A6Q47205789-C6F03A6C-4B87-426C-A65E-EC9C22BAEB65Q47366509-C51E0E68-CD80-489E-91AB-9D3C75E9491A
P2860
Cigarette smoking and mortality risk in people with schizophrenia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cigarette smoking and mortality risk in people with schizophrenia.
@ast
Cigarette smoking and mortality risk in people with schizophrenia.
@en
type
label
Cigarette smoking and mortality risk in people with schizophrenia.
@ast
Cigarette smoking and mortality risk in people with schizophrenia.
@en
prefLabel
Cigarette smoking and mortality risk in people with schizophrenia.
@ast
Cigarette smoking and mortality risk in people with schizophrenia.
@en
P2093
P2860
P356
P1476
Cigarette smoking and mortality risk in people with schizophrenia.
@en
P2093
Deanna L Kelly
Douglas L Boggs
Heidi J Wehring
Joo-Cheol Shim
Kimberly R Warren
Kristen M Mackowick
Lisa Dixon
Raymond C Love
Robert P McMahon
P2860
P304
P356
10.1093/SCHBUL/SBP152
P407
P577
2009-12-17T00:00:00Z